Detection of urine survivin in 40 patients with bladder cancer

Journal of Nippon Medical School

Volumn 71, Issue 6, 2004, Pages 379-383

  Ohsawa, Ikuroh ^a   Nishimura, Taiji ^a   Kondo, Yukihiro ^a   Kimura, Go ^a   Satoh, Mitsuhiro ^a   Matsuzawa, Ichiro ^a   Hamasaki, Tsutomu ^a   Ohta, Shigeo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Bladder tumor; Survivin

Indexed keywords

CYTOKERATIN 19 FRAGMENT; INHIBITOR OF APOPTOSIS PROTEIN; SURVIVIN; TUMOR MARKER;

ADULT; APOPTOSIS; ARTICLE; BLADDER CANCER; BLADDER TUMOR; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG URINE LEVEL; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN FAMILY; TISSUE SPECIFICITY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 12444317645     PISSN: 13454676     EISSN: None     Source Type: Journal    
DOI: 10.1272/jnms.71.379     Document Type: Article

References (14)

1. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK, OhBH: An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry 2001; 40: 1117-1123.
2. Ambrosini G, Adida C: Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-921.
3. Lu CD, Altieri DC, Tanigawa N: Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinoma. Cancer Res 1998; 58: 1808-1812.
4. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998; 58: 5071-5074.
5. Adida C, Berrebi D, Peuchmaur M, Reys-Mugica M, Altieri DC: Anti-apotosis gene, survivin, and prognosis of neuroblastoma. Lancet 1998; 351: 882-883.
6. Monzo M, ROsell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A, Abad A: A novel anti-apoptosis gene: re-expression of survivin messenger RNA as prognosis marker in non-small-cell lung cancers. J Clin Oncol 1999; 17: 2100-2104.
7. Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC: Tumor content of the antiapotosis molecule survivin and recurrence of bladder cancer. N Engl J Med 1999; 341: 452-453.
8. Asanuma K, Moriai R, Yajima T, Yagihashi A, Yamada M, Kobayashi D, Watanabe N: Survivin as radioresistance factor in pancreatic cancer. Jpn J Cancer Res 2000; 91: 1204-1209.
9. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N: Expression of survivin and its relationship to loss of apoptosis in breast carcinoma. Clin Cancer Res 2000; 6: 127-134.
10. Kishi H, Igawa M, Kikuno N, Yoshino T, Urakami S, Shiina H: Expression of the survivin gene in prostate cancer. J Urol 2004; 171: 1855-1869.
11. Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC: Urine detection of survivin and diagnosis of bladder cancer. JAMA 2001; 285: 324-328.
12. Senga Y, Kimura G, Hattori T, Yoshida K: Clinical evaluation of soluble cytokeratin 19 fragments (Cyfra 21-1) in serum and urine of patients with bladder cancer. Urology 1996; 48: 703-710.
13. Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan RC, BLute ML, O'Kane DJ: Comparison of screening methods in the detection of bladder cancer. J Urol 1999; 161: 388-394.
14. Mahotka C, Wenzel M, Soringer E, Gabbert HE, Gerharz CD: Survivin-ΔEx 3 and survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 1999; 59: 6097-6102.